agar, which was incubated in air for 4 days (6) . The isolate tested showed positivity for arabinose utilization and was negative for sucrose and maltose fermentation (2) . P. acidilactici was differentiated from P. pentosaceus by failure to ferment maltose (1) or sucrose (6) and the ability to utilize arabinose in cysteine-trypticase agar (6) . The antimicrobial susceptibility of our isolate was determined by the Kirby-Bauer disk diffusion method in Mueller-Hinton agar supplemented with 5% sheep blood following incubation for 18 h at 37°C. The organism was susceptible to penicillin G, ampicillin, chloramphenicol, gentamicin, netilmycin, norfloxacin, and ciprofloxacin (5-g disk zone diameters of 16 mm or larger) and resistant to vancomycin, cloxacillin, ceftazidime, ceftriaxone, cefoperazone, cefotaxime, cefazolin, cefuroxime, tetracycline, and erythromycin (zone diameters of 10 mm or smaller). The isolate did not exhibit intermediate susceptibility (zone diameters of 10 to 16 mm) to the antibiotics tested. While Tankovic et al. (9) and Golledge et al. (3) have reported susceptibility to penicillin, other reports have noted pediococci to be mostly moderately susceptible to penicillin and resistant to quinolones (2, (5) (6) (7) (8) .
Treatment with ceftriaxone was discontinued. Treatment with benzyl penicillin at 2 million U intravenously every 6 h was started. Defervescence occurred promptly, within 48 h. Therapy was continued for a total of 10 days. Subsequent cultures of blood and sputum remained sterile. The patient was discharged on the 15th hospital day. At follow-up 2 months later, she was well, with a normal fetus of 24 weeks' gestation. There appears to be little doubt that P. acidilactici is a rare clinical isolate and an opportunistic pathogen (7). This report underlines the importance of accurate identification of organisms found to be vancomycin-resistant; shows that pregnancy, with depressed humoral and polymorphonuclear functions beginning with the second trimester (4), is one of the underlying predisposing factors for P. acidilactici infection; and reveals the benefits of initiation of prompt and specific antibiotic therapy.
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